Kristina Lamberg
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Molecular Biology
- Cancer Research
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Gunnar HillerdalMats LambeGunnar MýrdalElisabeth StåhleChrister SederholmKarl KölbeckRonny WestbergMonika Dufmats
- Topics
- Lung Cancer Treatments and Mutations (8 papers)Lung Cancer Diagnosis and Treatment (6 papers)Lung Cancer Research Studies (3 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Kristina Lamberg
19 papers receiving 763 citations
Peers
Comparison fields: 5 of 83
- Pulmonary and Respiratory Medicine 427
- Oncology 414
- Molecular Biology 194
- Cancer Research 139
- Radiology, Nuclear Medicine and Imaging 68
Countries citing papers authored by Kristina Lamberg
This map shows the geographic impact of Kristina Lamberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Lamberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Lamberg more than expected).
Fields of papers citing papers by Kristina Lamberg
This network shows the impact of papers produced by Kristina Lamberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Lamberg. The network helps show where Kristina Lamberg may publish in the future.
Co-authorship network of co-authors of Kristina Lamberg
This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Lamberg. A scholar is included among the top collaborators of Kristina Lamberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Lamberg. Kristina Lamberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 16 | |
| 5 | 13 | |
| 6 | 62 | |
| 7 | 48 | |
| 8 | 47 | |
| 9 | Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer. | 7 |
| 10 | 35 | |
| 11 | Muscle paralysis and myosin loss in a patient with cancer cachexia. | 28 |
| 12 | 146 | |
| 13 | Effect of delays on prognosis in patients with non-small cell lung cancer. | 199 |
| 14 | 12 | |
| 15 | 55 | |
| 16 | 9 | |
| 17 | Alpha-2b interferon and oral clodronate for Gorham's disease [letter] | 12 |
| 18 | 18 | |
| 19 | Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. | 51 |
| 20 | 5 |
About Kristina Lamberg
Kristina Lamberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 20 papers that have together received 789 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (414 citations), Pulmonary and Respiratory Medicine (427 citations) and Cancer Research (139 citations). Kristina Lamberg has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Gunnar Hillerdal, Mats Lambe, Gunnar Mýrdal, Elisabeth Ståhle, Christer Sederholm, Karl Kölbeck, Ronny Westberg, Monika Dufmats, Gunnar Wagenius and Michael Bergqvist. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.